Literature DB >> 22212724

Ethics of clinical research with mentally ill persons.

Hanfried Helmchen1.   

Abstract

This article describes ethical, legal and professional components of the two core requirements of clinical research: informed consent and risk-benefit relationships. It deals particularly with the ethically relevant reasons, criteria, procedures and validity of (1) the informed consent process, (2) the relationship between benefits and risks, and as a requirement of its assessment: (3) standards and (quasi quantitative) criteria of benefits and risks and/or burdens of a research intervention. These requirements will be discussed with specific reference to research interventions in mentally ill patients, and particularly in those who are incompetent to consent. (4) The analysis concludes by demanding a strong adherence to the ethical rules of clinical research in order to protect participants and preserve the trust of both the patients and the public and (5) yields in a set of recommendations.

Entities:  

Mesh:

Year:  2012        PMID: 22212724     DOI: 10.1007/s00406-011-0287-2

Source DB:  PubMed          Journal:  Eur Arch Psychiatry Clin Neurosci        ISSN: 0940-1334            Impact factor:   5.270


  56 in total

1.  Relationships between authors of clinical practice guidelines and the pharmaceutical industry.

Authors:  Niteesh K Choudhry; Henry Thomas Stelfox; Allan S Detsky
Journal:  JAMA       Date:  2002-02-06       Impact factor: 56.272

2.  Dignity is a useless concept.

Authors:  Ruth Macklin
Journal:  BMJ       Date:  2003-12-20

Review 3.  Ethical issues in translational research.

Authors:  Carlo Petrini
Journal:  Perspect Biol Med       Date:  2010       Impact factor: 1.416

4.  Potential pitfalls of disease-specific guidelines for patients with multiple conditions.

Authors:  Mary E Tinetti; Sidney T Bogardus; Joseph V Agostini
Journal:  N Engl J Med       Date:  2004-12-30       Impact factor: 91.245

5.  Viewpoint: professional integrity in industry-sponsored clinical trials.

Authors:  Franklin G Miller; Howard Brody
Journal:  Acad Med       Date:  2005-10       Impact factor: 6.893

6.  Assessing research risks systematically: the net risks test.

Authors:  D Wendler; F G Miller
Journal:  J Med Ethics       Date:  2007-08       Impact factor: 2.903

7.  Evidence-based medicine in psychopharmacotherapy: possibilities, problems and limitations.

Authors:  Hans-Jürgen Möller; Wolfgang Maier
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02       Impact factor: 5.270

8.  Enrolling pregnant women in biomedical research.

Authors:  Ruth Macklin
Journal:  Lancet       Date:  2010-02-20       Impact factor: 79.321

9.  Principle standards and problems regarding proof of efficacy in clinical psychopharmacology.

Authors:  Hans-Jürgen Möller; Karl Broich
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-02       Impact factor: 5.270

Review 10.  Mental capacity in psychiatric patients: Systematic review.

Authors:  David Okai; Gareth Owen; Hugh McGuire; Swaran Singh; Rachel Churchill; Matthew Hotopf
Journal:  Br J Psychiatry       Date:  2007-10       Impact factor: 9.319

View more
  2 in total

1.  Biomarkers and neurobiology of schizophrenia.

Authors:  Peter Falkai; Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2012-08       Impact factor: 5.270

2.  Bioethical reflexivity and requirements of valid consent: conceptual tools.

Authors:  John Barugahare
Journal:  BMC Med Ethics       Date:  2019-07-04       Impact factor: 2.652

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.